News | Computed Tomography (CT) | August 15, 2022

Combo of deep-learning reconstruction and subtraction technique yielded optimal diagnostic performance for the detection of in-stent restenosis by coronary CTA 

57-year-old man who underwent coronary CTA using two-breath-hold subtraction technique to assess patency of coronary artery stent.

A. Conventional HIR image and B. conventional DLR image show blurred appearance of proximal aspect of stent (arrow). C. Subtraction HIR image and D. subtraction DLR image show discrete region of hypoattenuation at proximal aspect of stent (arrow). Both readers provided a diagnosis of in-stent restenosis only for subtraction HIR and subtraction DLR. Diagnostic confidence score for the four methods for reader 1 was 2, 2, 3, and 4, respectively, and for reader 2 was 1, 2, 3, and 3, respectively. Patient subsequently underwent invasive catheter angiography. Fluoroscopic imagines obtained (E) before and (F) after contrast media injection demonstrate in-stent restenosis of proximal aspect of stent (arrow). Image courtesy of ARRS and AJR 


August 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the combination of deep-learning reconstruction (DLR) and a subtraction technique yielded optimal diagnostic performance for the detection of in-stent restenosis by coronary CTA. 

Noting that these findings could guide patient selection for invasive coronary stent evaluation, combining DLR with a two-breath-hold subtraction technique “may help overcome challenges related to stent-related blooming artifact,” added corresponding author Yi-Ning Wang from the State Key Laboratory of Complex Severe and Rare Diseases at China’s Peking Union Medical College Hospital. 

Between March 2020 and August 2021, Wang and team studied 30 patients (22 men, 8 women; mean age, 63.6 years) with a total of 59 coronary stents who underwent coronary CTA using the two-breath-hold technique (i.e., noncontrast and contrast-enhanced acquisitions). Conventional and subtraction images were reconstructed for hybrid iterative reconstruction (HIR) and DLR, while maximum visible in-stent lumen diameter was measured. Two readers independently evaluated images for in-stent restenosis (≥50% stenosis). 

Ultimately, coronary CTA using DLR and subtraction technique—with a combined (conventional and subtraction images) interpretation—yielded PPV, NPV, and accuracy for in-stent restenosis for reader 1 of 73.3%, 93.2%, and 88.1%, and for reader 2 of 75.0%, 84.3%, and 83.1%, respectively. 

Acknowledging that the two-breath-hold subtraction technique requires an additional noncontrast acquisition (and thus a higher radiation dose), “DLR allows a reduction in radiation exposure, while improving image quality,” the authors of this AJR article pointed out

For more information: www.arrs.org 


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...

Time February 09, 2026
arrow
Subscribe Now